DR. EVELYNE DECLERCQ - INWENDIGE GENEESKUNDE - ENDOCRINOLOGIE
0667.997.428 · rovalta.com · 28/09/2026
DR. EVELYNE DECLERCQ - INWENDIGE GENEESKUNDE - ENDOCRINOLOGIE
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBODR. EVELYNE DECLERCQ - INWENDIGE GENEESKUNDE - ENDOCRINOLOGIE is a Private limited company incorporated in 2016. Its main activity is: Specialist medical practice activities. Its registered office is in Lievegem.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0667.997.428
- Incorporation
- 22/12/2016
- Legal form
- Private limited company
- Registered office
- Vijverstraat 16
9920 Lievegem · FlandreSee on map - Contributed capital
- 18 550,00 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 9 filingsTrend over 8 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 293,5 k € | +94.6% | 150,8 k € | -56.9% | 350,2 k € | -7.9% | 380,2 k € | +98.5% | 191,6 k € |
| EBITDA | 292,3 k € | +95.4% | 149,6 k € | -57.1% | 349 k € | -7.9% | 379,1 k € | +99.2% | 190,3 k € |
| Operating result | 261,2 k € | +118% | 119,6 k € | -63.4% | 327,1 k € | -10.0% | 363,5 k € | +108% | 174,8 k € |
| Net result | 214,1 k € | +126% | 94,7 k € | -62.0% | 249,1 k € | -9.5% | 275,3 k € | +104% | 135,1 k € |
| Balance sheet | |||||||||
| Equity | 169,2 k € | -20.5% | 212,9 k € | -3.3% | 220,1 k € | -31.4% | 320,9 k € | +8.6% | 295,6 k € |
| Total assets | 364,4 k € | +10.3% | 330,2 k € | -47.9% | 633,8 k € | -3.8% | 658,8 k € | +15.4% | 570,8 k € |
| Cash | 169,7 k € | +114% | 79,5 k € | -78.5% | 370,2 k € | -23.9% | 486,8 k € | +36.5% | 356,7 k € |
| Debts | 195,2 k € | +67.7% | 116,4 k € | -71.9% | 413,8 k € | +26.6% | 326,7 k € | +18.8% | 275,1 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Evelyne DECLERCQ | Directorsince 22/12/2016Managersince 22/12/2016ended |
Other companies at this address
Vijverstraat 16 9920 Lievegem| Company | CBE no. |
|---|---|
PURElations● Active | 0794.980.425 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 20/07/2026 | 28/08/2025 | 22/08/2024 | 03/07/2023 | 25/08/2022 | 30/08/2021 |
| General meeting | 24/06/2026 | 25/06/2025 | 26/06/2024 | 28/06/2023 | 29/06/2022 | 30/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 9 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 24/06/2026 | 20/07/2026 | Dutch | |
| Micro model | 31/12/2024 | 25/06/2025 | 28/08/2025 | Dutch | |
| Micro model | 31/12/2023 | 26/06/2024 | 22/08/2024 | Dutch | |
| Micro model | 31/12/2022 | 28/06/2023 | 03/07/2023 | Dutch | |
| Micro model | 31/12/2021 | 29/06/2022 | 25/08/2022 | Dutch | |
| Micro model | 31/12/2020 | 30/06/2021 | 30/08/2021 | Dutch | |
| Micro model | 31/12/2019 | 24/06/2020 | 28/08/2020 | Dutch | |
| Micro model | 31/12/2018 | 26/06/2019 | 31/07/2019 | Dutch | |
| Micro model | 31/12/2017 | 27/06/2018 | 05/07/2018 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Evelyne DECLERCQ | Directorsince 22/12/2016Managersince 22/12/2016ended |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Vijverstraat 16, 9920 LovendegemCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00309812 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| DR. EVELYNE DECLERCQ - INWENDIGE GENEESKUNDE - ENDOCRINOLOGIECurrent | accounts 2024 → 2025 | Accounts 2025 · 2026-00309812 |
| Dr Evelyne Declercq | accounts 2021 → 2023 | Accounts 2023 · 2024-00359501 |
Events
- 2025Annual accounts 2025214,1 k €↑
- 2024Annual accounts 202494,7 k €↓
- 2024Name changeDR. EVELYNE DECLERCQ - INWENDIGE GENEESKUNDE - ENDOCRINOLOGIE
- 2023Annual accounts 2023249,1 k €↓
- 2022Annual accounts 2022275,3 k €↑
- 2021Annual accounts 2021135,1 k €↓
- 2019Annual accounts 2019136,5 k €↑
- 2018Annual accounts 201857,8 k €↓
- 2017Annual accounts 2017133 k €
- 22/12/2016IncorporationPrivate limited company